ClinConnect ClinConnect Logo
Search / Trial NCT06786364

Types of Photoplethysmographic Waves in Adult Patients with Septic Shock

Launched by HOSPITAL GENERAL DE MÉXICO DR. EDUARDO LICEAGA · Jan 15, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Shock Septic Waveform Vasodilation Photoplethysmography Arterial Tone

ClinConnect Summary

This clinical trial is studying how certain types of waves detected by a special device called a photoplethysmograph relate to septic shock in adults. Septic shock is a serious condition that occurs when an infection leads to dangerously low blood pressure and reduced blood flow to the organs. The researchers want to see if these waves can provide important information about how well blood is flowing in the body, which can be measured using other indicators like capillary refill time, serum lactate levels, and mottling score.

To participate in this study, you need to be at least 18 years old and diagnosed with septic shock. You should also have a body temperature above 36°C and be able to lie flat comfortably. However, if you have other types of shock, a history of certain heart problems, chronic liver disease, or conditions that might affect the readings from the device, you may not be eligible. If you decide to join, you will be asked to sign a consent form. This study is currently looking for participants, and your involvement could help improve understanding and treatment of septic shock in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients of 18 years of age and above dignossed with septic shock according to the definition stated in Sepsis 3.0
  • Patients with axillary temperature above 36°C
  • Patients and/or family that agree to participate in such study and sign the informed consentment
  • Patients that tolerate supine position
  • Exclusion Criteria:
  • Patients with Cardiogenic shock, hipovolemic, obstructive and distributive (neurogenic, anafilactic) shock the exception being septic shock
  • Patients with history of any type of cardiac arrhythmia
  • Patients with history of chronic hepatic disease
  • Patients with limited or diffuse systemic sclerosis
  • Patients that have scarring, nail polish or thickened nails that may impede the proper placement and accurate measurement of photoplethysmography with the pulse oximeter
  • Patients with history of heart insufficiency P- atients with septic shock that already have vasopressor aggents

About Hospital General De México Dr. Eduardo Liceaga

Hospital General de México Dr. Eduardo Liceaga is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. As a prominent sponsor of clinical trials, the hospital focuses on innovative therapeutic strategies and patient-centered studies that aim to enhance treatment outcomes across various medical specialties. With a commitment to ethical standards and patient safety, the hospital collaborates with multidisciplinary teams of experienced researchers and healthcare professionals to contribute to the advancement of medical knowledge and improve healthcare delivery in Mexico and beyond.

Locations

Mexico City, Cuauhtemoc, Mexico

Patients applied

0 patients applied

Trial Officials

Juan Fernando Bautista Garcia, MD

Principal Investigator

Hospital General de México Dr. Eduardo Liceaga

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported